Robinetin

Robinetin

SCHEMBL217743

O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)ccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 1.00
KMT2A Q03164 11/20 1.00
RECQL P46063 4/20 1.00
TDP1 Q9NUW8 4/20 1.00
ABCC1 P33527 3/20 1.00
CD38 P28907 2/20 1.00
CYP3A4 P08684 11/20 0.78
HSD17B10 Q99714 10/20 0.78
KDM4E B2RXH2 9/20 0.78
MAPT P10636 9/20 0.78
ALDH1A1 P00352 8/20 0.78
CYP2C9 P11712 8/20 0.78
HPGD P15428 7/20 0.78
ALOX15 P16050 7/20 0.78
CASP7 P55210 5/20 0.78
MAPK1 P28482 5/20 0.78
TP53 P04637 5/20 0.78
CASP1 P29466 4/20 0.78
FTO Q9C0B1 4/20 0.78
CDK5 Q00535 3/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Robinetin SCHEMBL29883566 1.00 MEN1 (1.00) MEN1KMT2ARECQLTDP1ABCC1
Robinetin SCHEMBL9063852 0.93 MEN1 (0.92) MEN1KMT2ARECQLTDP1ABCC1
SCHEMBL19213535 0.90 MEN1 (0.82) MEN1KMT2ARECQLTDP1ABCC1
Fisetin SCHEMBL29381611 0.88 MEN1 (1.00) MEN1KMT2ARECQLTDP1ABCC1
Fisetin SCHEMBL116861 0.88 MEN1 (1.00) MEN1KMT2ARECQLTDP1ABCC1
Fisetin SCHEMBL29349742 0.88 MEN1 (1.00) MEN1KMT2ARECQLTDP1ABCC1
Fisetin SCHEMBL29394036 0.88 MEN1 (1.00) MEN1KMT2ARECQLTDP1ABCC1
Fisetin SCHEMBL39454 0.88 MEN1 (1.00) MEN1KMT2ARECQLTDP1ABCC1
Resokaempferol SCHEMBL344710 0.87 MEN1 (1.00) MEN1KMT2ARECQLTDP1ABCC1
Resokaempferol SCHEMBL30873045 0.87 MEN1 (1.00) MEN1KMT2ARECQLTDP1ABCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698662-A2 REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES AskBio Inc. (US) 2026-02-25 EP claimed
EP-2603098-B1 METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER FIRMENICH INCORPORATED (US) 2025-08-06 EP claimed
EP-4580594-A1 ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-07-09 EP claimed
WO-2024220449-A9 REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES AskBio Inc. (US) 2025-04-03 WO claimed
EP-3849935-B1 DELIVERING TAP WITH INTERNAL VALVE WITH FLEXIBLE EDGES AND MULTIPLE SEALS VITOP MOULDING SRL (IT) 2024-11-06 EP claimed
WO-2024220449-A2 REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES ASKLEPIOS BIOPHARMACEUTICAL, INC. (US) 2024-10-24 WO claimed
WO-2024046834-A1 ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS ANALYTICON DISCOVERY GMBH (DE) 2024-03-07 WO claimed
EP-4331564-A1 ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS Analyticon Discovery GmbH (DE) 2024-03-06 EP claimed
WO-2023150072-A1 COMPOSITIONS AND METHODS FOR THE PRESERVATION OF PLANT MATTER SINCLAIR DAVID A (US) 2023-08-10 WO claimed
US-20200253920-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COUNTERING CHEMOTHERAPY INDUCED CARDIOTOXICITY AURANSA INC. (US) 2020-08-13 US claimed
CN-1078984-A The acrylonitrile butadiene copolymer rubber adhesive LORD CORP (US) 1993-12-01 CN claimed
WO-1993022390-A1 ACRYLONITRILE-BUTADIENE COPOLYMER RUBBER ADHESIVE LORD CORPORATION (US) 1993-11-11 WO claimed
US-5162156-A PHENOLIC RESIN ADHESION PROMOTERS AND ADHESIVE COMPOSITIONS, AND BONDING METHOD EMPLOYING SAME LORD CORPORATION (US) 1992-11-10 US claimed
WO-1992018566-A1 HIGH-TEMPERATURE ADHESIVE COMPOSITIONS LORD CORPORATION (US) 1992-10-29 WO claimed
CN-1065672-A The high-temperature adhesives composition LORD CORP (US) 1992-10-28 CN claimed
EP-0508650-A2 High-temperature adhesive compositions LORD CORPORATION (US) 1992-10-14 EP claimed
EP-0496349-A1 Coating solution for preventing adhesion of polymer scale and method for its use SHIN-ETSU CHEMICAL CO., LTD. (JP) 1992-07-29 EP claimed
US-5128403-A A mixture of perhalocyclic diene-modified polyconjugated diene, phenolic resin, a phenol, an aldehyde, thermosensitive elastomer crosslinker, vulcanizer and metal oxide; bonding metal and elastomer; heat resistance LORD CORPORATION (US) 1992-07-07 US claimed
EP-0476902-A2 Phenolic resin adhesion promoters and adhesive compositions LORD CORPORATION (US) 1992-03-25 EP claimed
US-4617293-A Flavonoid phosphate salts of aminoglycoside antibiotics MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 1986-10-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200253920-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COUNTERING CHEMOTHERAPY INDUCED CARDIOTOXICITY RDX, TNNT2, CHLSN MEN1 1453/4885KMT2A 1476/4885RECQL 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.